Find Nonprofit and Small Business Grants

Advance Search

Only Available for Paid Subscribers
Clear Filters
Search Filters

Grants to USA, Canada, and International Researchers for Epilepsy-Related Studies

CURE Taking Flight Award


GrantWatch ID#

Funding Source
Array ( [0] => American Samoa (USA); [1] => Guam (USA); [2] => Puerto Rico (USA); [3] => Virgin Islands (USA); [4] => Northern Mariana Islands (USA); )

Geographic Focus
USA Territories: American Samoa (USA);   Guam (USA);   Puerto Rico (USA);   Virgin Islands (USA);   Northern Mariana Islands (USA);
USA Compact Free Associations:The Federated States of Micronesia (USA)   Marshall Islands (USA)   Republic of Palau (USA)
International, Israel and Canada.

Important Dates
LOI Date: 01/09/24
Deadline: 03/26/24 9:00 PM ET Save

Grant Description
Grants to USA, Canada, and International researchers for projects related to epilepsy prevention, therapy, and treatments. Applicants must submit a letter of intent prior to applying. The goal of the program is to encourage young researchers to develop independent studies that are distinct from that of their mentors.

Researchers may propose basic or clinical studies, but this award mechanism is not intended to support clinical trials. Research that involves collaboration and a multidisciplinary approach is desirable. Studies that will provide new directions for epilepsy therapy, prevention, and, ultimately, a cure and that will allow applicants to collect the data necessary to support a grant application to the National Institutes of Health or a similar granting agency are encouraged. 

CURE Epilepsy encourages applications from groups underrepresented in the biomedical, clinical, behavioral, and social sciences. These groups include individuals with disabilities, veterans, persons from underrepresented racial and ethnic groups and gender-diverse groups, women in biomedical-related disciplines, or any legally protected characteristic.

Priority Areas

CURE Epilepsy’s priority research areas focus on those that have the potential to truly transform and save lives. Prevention, disease modification and elimination are critical goals and consistent with CURE Epilepsy's mission. 

  • Transformative research to enhance understanding of the cellular, molecular, genetic and systems-level mechanisms that lead to any of the epilepsies, facilitating the continued investigation of disease-modifying or preventative strategies
  • Innovative approaches that can prevent, modify and/or arrest the development of acquired epilepsy. Examples include epilepsy that develops after stroke, tumor, traumatic brain injury or infection, including febrile infection-related epilepsy syndrome (FIRES) as well as new-onset refractory status-epilepticus (NORSE)
  • Research that will inform the development of novel therapies to prevent onset or halt the progression of severe pediatric epilepsies
  • Research focused on new, effective treatments for the >30% of the epilepsy population who are pharmacoresistant
  • Novel research that furthers understanding of the causes and ultimate elimination of SUDEP
  • Translational, clinical, and clinically informed basic research that will facilitate understanding of the cellular-, molecular-, and systems-level mechanisms that underlie the relationships between sleep and epilepsy

Funding requests may include salary support for the Principal Investigator (PI), technical staff, supplies necessary to perform the work, animal costs, publication fees, and travel to an epilepsy-related conference if the PI is presenting his/her CURE Epilepsy-funded research. 

For additional information on eligible costs, see:


Additional Eligibility Criteria
Applicants must generally fall into one of the following categories to be eligible for the Taking Flight Award:
- A postdoctoral fellow with a PhD, PsyD, PharmD, or equivalent and a minimum of two years postdoctoral experience at the time of submission. Applicants must submit a letter of support from their direct supervisor/mentor. For applicants with less than three years of post-doctoral experience, this letter must include a statement from the mentor, clearly articulating a plan to guide the applicant through the project, helping them develop an independent research focus, and encouraging them to think independently and strategically.
- A researcher with an appointment as an Instructor or Research Assistant Professor who has yet to obtain significant funding (e.g., RO1 grant or equivalent) and has an on-site mentor committed to advising the applicant.
- A faculty member at the assistant professor level who is within one year of having been appointed.
- Clinician-researchers who are within two years of their faculty appointment.
- A clinical fellow who is pursuing a residency in the following areas: neurology, neurosurgery or neurocritical care, and considering an epilepsy-focused fellowship.

International applicants are welcome; you do not have to be a US citizen or working in the US to apply for this award.

Researchers who have already received significant funding (e.g., NIH K99 award or equivalent) are not eligible for CURE Epilepsy funding.

Based on CURE Epilepsy’s current research objectives, lower priority will be given for research in the following areas:
- Research that focuses solely on a comorbid condition without also seeking to address/understand the accompanying epilepsy
- Research that focuses solely on improving localization of the epileptic seizure focus

Funds are not to be used to purchase equipment. Indirect costs are not supported.

Funds cannot be used to cover institutional expenses such as network charges, computer maintenance and services, insurance dues or other miscellaneous expenses not directly related to performing the project.

Pre-Application Information
Key Dates:
- Request for Proposals: Monday, November 27, 2023
- Letter of Intent Deadline: Tuesday, January 9, 2024 – 9pm ET
- Full Application Invitations: Tuesday, February 20, 2024
- Full Application Deadline: Tuesday, March 26, 2024 – 9pm ET
- Anticipated Award Announcement: July 2024
- Anticipated Project Start Date: September 2024

All applicants must submit a Letter of Intent (LOI). Following review of LOIs, select applicants will be invited to submit full proposals.

All materials must be submitted in English.

There is no limit to the number of researchers from the same institution who can apply for the same grant.

Grant Process:

For additional relevant links, see the Full Grant Text RFP link.

Estimated Size of Grant
Requests may be made for up to $125,000.

Term of Contract
- Eighteen months
- Anticipated Project Start Date: September 2024
- CURE Epilepsy does not provide deadline extensions.

Contact Information
Apply online:

Questions regarding these guidelines are welcome and should be directed to the Research Team at or 312-255-1801.

420 N. Wabash Avenue, Suite 650
Chicago, IL 60611

Mailing address:
PO Box 10572
Chicago, IL 60610

Grant News
Live Chat Chat Now